- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04671368
Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology
A Multi-center, Prospective, Self-Controlled Diagnostic Accuracy Comparative Studies of Artificial Intelligence Diagnostic System for Surgical Neuropathology
Studie Overzicht
Toestand
Gedetailleerde beschrijving
In this study, 141 patients will be recruited. After being enrolled, the patients will accept surgery and specimens for pathological analysis will be taken according to the routine treatment process.
The histopathologic slides will then be digitized by a whole-slide scanner. The images will be reviewed by gold standard committee for evaluation of ground truth. And then be separately diagnosed by Artificial Intelligence Diagnostic System and practicing pathologists. So the investigators can compare the diagnostic efficiency of Artificial Intelligence with that of pathologists, thus understand the gap between artificial intelligence and actual clinical practice.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Patients or their guardians understand the research process, agree to use their data, and sign the informed consent form;
- Aged >=18 years;
- MRI shows intracranial spaceoccupying lesions;
- The clinical diagnosis is glioma, metastasis or lymphoma thus requiring surgical treatment;
- The patient is willing to accept the surgery.
Exclusion Criteria:
- The patient has serious underlying diseases thus is not suitable for surgery;
- After further clinical evaluation, surgical treatment was not the best choice;
- The patient participate in clinical research of other drugs or devices;
- The researchers believe that there are other factors that will make the patients unable to complete the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Diagnostisch
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Artificial Intelligence
A deep learning based artificial intelligence diagnostic system(DOI:10.1093/neuonc/noaa163)
|
The investigators will use the Artificial Intelligence Diagnostic System to review the H&E stained slide of each patient and then report the classification of the tumor on a 10-type scale.
|
|
Actieve vergelijker: Practicing Pathologists
One pathologist who has at least 5 years of experience
|
The ordinary pathologist will review the H&E stained slide of each patient(without additional informations such as: Immunohistochemistry et al.) and then report the classification of the tumor on a 10-type scale only bases on the slide images
|
|
Ander: Gold Standard
A committee composed of two expert pathologists who has at least 10 years of experience and one expert pathologist who has at least 15 years of experience
|
Firstly, the two expert pathologist(>=10 years of experience) will review the H&E stained slide of each patient on their own (with additional informations such as: Immunohistochemistry et al.) and then report the classification of the tumor on a 10-type scale.If they report the same opinion, that opinion will perform as the ground truth; while if their opinion clash with each other, the expert pathologist(>=15 years of experience) will get involved and the agreement of three experts will perform as the ground truth
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Diagnostic Accuracy of Study Arms
Tijdsspanne: 1 week after the last patient's diagnosis is completed
|
The number of correctly diagnosed participants by study arms divided by the total number of participants
|
1 week after the last patient's diagnosis is completed
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Sensitivity and specificity of Study Arms
Tijdsspanne: 1 week after the last patient's diagnosis is completed
|
Sensitivity and specificity of study arms for each type calculated by 2x2 tables
|
1 week after the last patient's diagnosis is completed
|
|
Spearman Coefficient of Study Arms related to Gold Standard
Tijdsspanne: 1 week after the last patient's diagnosis is completed
|
Spearman Correlation Analysis between Study Arms and Gold Standard
|
1 week after the last patient's diagnosis is completed
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Cuiyun Wu, Ph.D, Huashan Hospital
Studie record data
Bestudeer belangrijke data
Studie start (Verwacht)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PAAI2020
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .